FDA Roundup: April 15, 2022
For Immediate Release: April 15, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On April 14, the FDA issued an emergency use authorization (EUA) to InspectIR Systems for their InspectIR COVID-19 Breathalyzer test. The InspectIR COVID-19 Breathalyzer test is the first COVID-19 diagnostic test […]
